Tag: Alzheimer’s treatment
Biotech Update: Roche’s TIGIT Struggles and Missed Alzheimer’s Target
Happy Tuesday! I'm Adam Feuerstein, and I'm here to bring you the latest updates in the world of biotech. It seems like all the...
Assessing the Cost-Effectiveness of Alzheimer’s Drug Donanemab in the U.K.
The recent decision by the U.K.'s National Institute for Health and Care Excellence (NICE) regarding the cost-effectiveness of the Alzheimer's drug Donanemab, also known...
BREAKING NEWS
USAID Workers Placed on Leave, Ordered to Return Home
Amidst the hustle and bustle of Washington, a significant shift in the Trump administration's policies has rocked the U.S. Agency for International Development (USAID)...
